FDA device listing

ACE Cholesterol Reagent (Axcel, plasma),ACE HDL-C Reagent (Axcel, plasma),ACE LDL-C Reagent (Axcel, plasma),ACE…

FDA device listing 1319082072 · Carr Biosystems, LLC

Key facts

Proprietary names ACE Cholesterol Reagent (Axcel, plasma),ACE HDL-C Reagent (Axcel, plasma),ACE LDL-C Reagent (Axcel, plasma),ACE Triglycerides Reagent (Axcel, plasma)
Owner/operator Carr Biosystems, LLC
Owner/operator number 10028192
Premarket submissions K122757
Product codes CDT, CHH, LBS, MRR
Device names CDT - Lipase Hydrolysis/Glycerol Kinase Enzyme, Triglycerides, CHH - Enzymatic Esterase--Oxidase, Cholesterol, LBS - Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl, MRR - System, Test, Low Density, Lipoprotein
Device class Class I
Classification regulations (21 CFR) 862.1175, 862.1475, 862.1705
Review panels Clinical Chemistry
Registered establishments ALFA WASSERMANN
Establishment registrations 2247288
FEI numbers 1000122044
Establishment operations Complaint File Establishment, Repackager/Relabeler, Specification Developer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • None UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings